Biocryst Pharmaceuticals Inc (BCRX)
EBITDA Margin
45.22%
Quarterly · Period ending:
BCRX EBITDA Margin
Latest reported45.22%period ending
Latest reported45.22%period ending
BCRX Quarterly EBITDA Margin (-1300.00% → 45.22%)
Quarterly ebitda margin
High-resolution chart · PNG
BCRX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 8.393% | |
| -331.5789% | |
| 369.4096% | |
| -3,000% | |
| -469.917% | |
| -43.2108% | |
| 0% | |
| -2,499% | |
| -14% | |
| -1,200% | |
| -425% | |
| 41.6667% | |
| -2,900% | |
| -3,100% | |
| 0% | |
| -2,600% | |
| -164.2857% | |
| -680% | |
| -400% | |
| -766.6667% | |
| -64.7059% | |
| -1,800% | |
| -2,100% | |
| -2,000% | |
| -1,600% | |
| -1,350% | |
| -900% | |
| -750% | |
| -1,800% | |
| -1,300% |